Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Perri

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Acta Obstetricia Et Gynecologica Scandinavica|February 2, 1999
A histological and immunohistochemical study of neuropeptide containing somatic nerves in the levator ani muscle of women with genitourinary prolapseP Busacchi, R De Giorgio, D Santini, et al.
Urology|March 19, 2004
Abnormalities of somatic peptide-containing nerves supplying the pelvic floor of women with genitourinary prolapse and stress urinary incontinenceP Busacchi, T Perri, R Paradisi, et al.
Cancer Research|July 1, 1992
Immunohistochemical identification of P-glycoprotein in previously untreated, diffuse large cell and immunoblastic lymphomasG A Niehans, W Jaszcz, V Brunetto, et al.
Gynecologic Oncology|December 21, 2013
Exposure of fallopian tube epithelium to follicular fluid mimics carcinogenic changes in precursor lesions of serous papillary carcinomaK Bahar-Shany, H Brand, S Sapoznik, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 26, 2013
Bowel obstruction in recurrent gynecologic malignancies: defining who will benefit from surgical interventionT Perri, J Korach, G Ben-Baruch, et al.
Leukemia & Lymphoma|March 26, 2002
High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150S M Lichtman, G Petroni, R L Schilsky, et al.
Pediatric Hematology and Oncology|July 17, 2001
Effect of P-glycoprotein expression on outcome in the Ewing family of tumorsT Perri, M Fogel, S Mor, et al.
Applied and Environmental Microbiology|December 6, 2023
Distinct microbial communities degrade cellulose diacetate bioplastics in the coastal oceanYanchen Sun, Michael G Mazzotta, Carolyn A Miller, et al.
Critical Reviews in Oncology/Hematology|March 19, 2025
Management of early-stage ovarian cancer: Open questions and debated issuesV Salutari, E Giudice, E Rapisarda, et al.
ESMO Open|July 18, 2022
Combining PARP inhibition and immune checkpoint blockade in ovarian cancer patients: a new perspective on the horizon?L Musacchio, C M Cicala, F Camarda, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Acta Obstetricia Et Gynecologica Scandinavica|February 2, 1999
A histological and immunohistochemical study of neuropeptide containing somatic nerves in the levator ani muscle of women with genitourinary prolapseP Busacchi, R De Giorgio, D Santini, et al.
Urology|March 19, 2004
Abnormalities of somatic peptide-containing nerves supplying the pelvic floor of women with genitourinary prolapse and stress urinary incontinenceP Busacchi, T Perri, R Paradisi, et al.
Cancer Research|July 1, 1992
Immunohistochemical identification of P-glycoprotein in previously untreated, diffuse large cell and immunoblastic lymphomasG A Niehans, W Jaszcz, V Brunetto, et al.
Gynecologic Oncology|December 21, 2013
Exposure of fallopian tube epithelium to follicular fluid mimics carcinogenic changes in precursor lesions of serous papillary carcinomaK Bahar-Shany, H Brand, S Sapoznik, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 26, 2013
Bowel obstruction in recurrent gynecologic malignancies: defining who will benefit from surgical interventionT Perri, J Korach, G Ben-Baruch, et al.
Leukemia & Lymphoma|March 26, 2002
High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150S M Lichtman, G Petroni, R L Schilsky, et al.
Pediatric Hematology and Oncology|July 17, 2001
Effect of P-glycoprotein expression on outcome in the Ewing family of tumorsT Perri, M Fogel, S Mor, et al.
Applied and Environmental Microbiology|December 6, 2023
Distinct microbial communities degrade cellulose diacetate bioplastics in the coastal oceanYanchen Sun, Michael G Mazzotta, Carolyn A Miller, et al.
Critical Reviews in Oncology/Hematology|March 19, 2025
Management of early-stage ovarian cancer: Open questions and debated issuesV Salutari, E Giudice, E Rapisarda, et al.
ESMO Open|July 18, 2022
Combining PARP inhibition and immune checkpoint blockade in ovarian cancer patients: a new perspective on the horizon?L Musacchio, C M Cicala, F Camarda, et al.
Pageof 6